A flibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway.
Sign Up to like & getrecommendations! Published in 2019 at "Biochemical pharmacology"
DOI: 10.1016/j.bcp.2019.07.021
Abstract: Diabetic retinopathy (DR) is a secondary complication of diabetes. DR can cause irreversible blindness, and its pathogenesis has been considered multifactorial. DR can progress from non-proliferative DR to proliferative DR, characterized by retinal neovascularization. The… read more here.
Keywords: aflibercept anti; retinal inflammation; plgf; flibercept regulates ... See more keywords